Combining data from ensemble docking in silico, binding interactions in vitro and in vivo, and experiments in intact cells and mouse models, we show that NSC290956 specifically binds to the “open conformation” structure, effectively attenuates KRas functions, and significantly reduces NSCLC cell survival and xenograft tumor growth in mice. This evidence concerns the gene KRAS and neoplasm.